CLINICAL_TRIALS
trial_result
· 2022-10-07
Clinical Trial Update: Oral DS107 in Moderate to Severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial update for oral DS107 in moderate to severe atopic dermatitis has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dignity Sciences Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-10-07